A carregar...
Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
Melanoma, an immunogenic tumor, is the first indication where oncolytic viruses are now becoming part of clinical practice. ONCOS‐102, a transgened adenovirus, has shown to act as a primer of relevant tumor targeting immune cells both in preclinical and clinical melanoma studies. Strategies to augme...
Na minha lista:
| Publicado no: | J Med Virol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6771875/ https://ncbi.nlm.nih.gov/pubmed/31081549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25501 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|